| ISPOR, co-sponsored with the U.S. Health and Human Services, Agency for Health Care Policy and Research, and the Health Outcomes Work Group of the
Pharmaceutical Research and Manufacturers of America, convened an Advisory Panel Meeting and Conference on Pharmacoeconomic Issues, February, 1998. The objective of this interdisciplinary conference was to identify the issues in conducting pharmacoeconomic studies, interpreting the results of these studies, and using pharmacoeconomic information in health care decisions. The results of this meeting and conference are summarized in Pharmacoeceonomics: Identifying the Issues Advisory Panel Reports.
|
